Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

ST3GAL5

ST3 beta-galactoside alpha-2,3-sialyltransferase 5

translation score 0.54, read 2026-10-27; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.01 from other evidence0.00
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in pituicytes/fscs0.75
chemistry
Open Targets
reachable by antibody0.36
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
4 Parkinson's papers of 1300.79
pathways
Reactome
2 pathways; mostly lysosome and autophagy1.00

No case: the score is under the bar. Receipt 11807

Sealed predictions

  1. ST3GAL5 in dopamine neurons, braak-0.01 (p 0.982) → -0.05 (p 0.907)receipt 11814
  2. ST3GAL5 in oligodendrocytes, braak-0.22 (p 0.576) → +0.30 (p 0.426)receipt 11813

Swarm cases

receipt 11814: ST3GAL5 in dopamine neurons, braak

power
full sample -0.08 (p 0.754, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.03 (p 0.908, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.01 (p 0.969, n 18). could be the mix.
skeptic
leave-one-out range -0.23 to +0.05, sign flips 2; without severely affected donors -0.08 (p 0.754, n 18). fragile.
cell type
strongest in microglia: -0.76 (p 2.7e-4, n 18) vs -0.08 in dopamine neurons. proposing microglia.
axis
no measure beats "tracks Braak Lewy-body stage" for ST3GAL5 in dopamine neurons.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ST3GAL5 · microglia · braak: substantia nigra, an independent cohort (already registered)

receipt 11813: ST3GAL5 in oligodendrocytes, braak

power
full sample +0.05 (p 0.854, n 18), 95% CI -0.43 to +0.50. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.06 (p 0.807, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.04 (p 0.888, n 18). could be the mix.
skeptic
leave-one-out range -0.05 to +0.20, sign flips 4; without severely affected donors +0.05 (p 0.854, n 18). fragile.
cell type
strongest in microglia: -0.76 (p 2.7e-4, n 18) vs +0.05 in oligodendrocytes. proposing microglia.
axis
no measure beats "tracks Braak Lewy-body stage" for ST3GAL5 in oligodendrocytes.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ST3GAL5 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.57 p 0.041 (needs p < 1.9e-4)

Receipts

loading the receipts